PDL BioPharma Inc (NASDAQ:PDLI)

7.10
Delayed Data
As of Mar 05
 +0.14 / +2.01%
Today’s Change
6.52
Today|||52-Week Range
10.26
-7.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues362.0M374.5M442.9M581.2M
 
 
 
 
 
Depreciation And Amortization1.4M946.0K5.6M--
 
 
 
 
 
Operating ExpensesGross Income----437.3M--
 
 
General Expenses16.9M24.5M29.8M34.9M
 
 
 
 
 
Total Operating Expenses18.3M25.5M35.4M34.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income343.7M349.1M407.5M546.3M
 
 
 
 
 
Extraordinary Charge-766.0K0.000.00-6.1M
 
 
 
Interest Expense On Debt36.1M29.0M24.9M39.2M
 
 
 
 
 
Other Expenses0.00391.0K0.00--
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income307.4M327.1M401.9M501.3M
 
 
 
 
 
Income Taxes-108.0M-115.5M-137.3M-179.0M
 
 
 
 
 
Net Income199.4M211.7M264.5M322.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS139.7M139.7M139.8M158.2M
 
 
 
 
 
Shares To Calculate EPS Diluted177.4M146.4M159.3M173.1M
 
 
 
 
 
 
Earnings Per ShareEPS$1.15$1.45$1.66$1.86
 
 
 
 
 
EPS Diluted$1.15$1.45$1.66$1.86
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account